Timbrell J A, Wright J M, Baillie T A
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):602-8. doi: 10.1002/cpt1977225part1602.
The potent hepatotoxin, acetylhydrazine (monoacetylhydrazine), has been identified by gas chromatography-mass spectrometry as a urinary metabolite of isoniazid in man. Using a specific gas chromatographic assay procedure for acetylhydrazine, the urinary excretion of this metabolite in volunteers given a 300-mg dose of isoniazid was found to be 1.8 +/- 0.4% and 2.5 +/- 0.5% of the dose in the rapid and slow acetylators, respectively. In the same subjects the urinary excretion of diacetylhydrazine was significantly greater in the rapid acetylators, 23.0 +/- 2.0%, than in the slow acetylators, 4.9 +/- 0.9%. The results suggests that only part of the acetylhydrazine formed as a metabolite of isoniazid is excreted in the urine as acetylhydrazine and diacetylhydrazine and that a substantial proportion of the acetylhydrazine formed is further metabolized, possibly through the microsomal enzyme pathway known to be responsible for hepatotoxicity in experimental animals.
强效肝毒素乙酰肼(单乙酰肼)已通过气相色谱 - 质谱法鉴定为人异烟肼的尿液代谢产物。采用针对乙酰肼的特定气相色谱测定方法,发现给予300毫克异烟肼剂量的志愿者中,快速乙酰化者和慢速乙酰化者尿液中该代谢产物的排泄量分别为给药剂量的1.8±0.4%和2.5±0.5%。在相同受试者中,快速乙酰化者二乙酰肼的尿液排泄量显著高于慢速乙酰化者,分别为23.0±2.0%和4.9±0.9%。结果表明,作为异烟肼代谢产物形成的乙酰肼只有一部分以乙酰肼和二乙酰肼的形式经尿液排泄,并且形成的乙酰肼相当一部分会进一步代谢,可能是通过已知在实验动物中导致肝毒性的微粒体酶途径。